Delivery Order SPE2DB22D2206-SPE2DB25FDW32
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,184.60 firm fixed-price delivery order covers the supply of EVEROLIMUS 5 MG TABLET UD 28S, with an ultimate completion date of October 17, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,627.10, is a delivery order for EVEROLIMUS 0.25 MG TABLET 60S. It has a firm fixed price pricing type and an ultimate completion date of March 20, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,788.61 firm fixed-price delivery order contract is for the supply of EVEROLIMUS 0.5 MG TABLET 60S, a specialty pharmaceutical product. The contract has an ultimate completion date of November 6, 2024 and was awarded on November 5, 2022. It is not designated as a set-aside contract. Amerisourcebergen holds a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $22,073.21, is for the delivery of EVEROLIMUS 0.5 MG TABLET 60S, a prescription medication. The contract is a Delivery Order type with a Firm Fixed Price pricing structure, and has an ultimate completion date of April 8, 2025. It is not designated as a set-aside contract. AmerisourceBergen Drug...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $5,847.13, is a delivery order for the supply of Everolimus 10 mg tablets. The contract has an ultimate completion date of November 8, 2024 and is a firm fixed-price arrangement. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 0.5 mg Everolimus tablets, with a ceiling value of $13,739.02 and a period of performance through June 16, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Everolimus 10 mg tablets (quantity 30) under a firm fixed-price contract valued at $12,749.86, with an ultimate completion date of December 12, 2025. This non-set-aside award represents a competitively awarded transaction for pharmaceutical supply supporting federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of Everolimus 1 mg tablets in unit dose packaging (60 count) with a ceiling value of $4,250.58. This is a firm fixed price delivery order with no set-aside designation, indicating the award was competitively procured. The order is scheduled for ultimate completion by December 30, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Everolimus 5 mg tablets (30-count) under a firm fixed-price contract valued at $5,473.37, with an ultimate completion date of November 21, 2025. This non-set-aside award was competitively procured and represents a single delivery order transaction within AmerisourceBergen's broader federal pharmaceutical supply portfolio. The contract will be performed at the vendor's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 19, 2025, for the supply of Everolimus 5 mg tablets (30-count units) with a ceiling value of $52,818.78. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 22, 2025, and will be performed at the vendor's Conshohocken, Pennsylvania location. The award carries no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to compete...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FDW32Delivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,468.00 firm fixed price delivery order is for the supply of 4566165476 EVEROLIMUS 10 MG TABLET 30S, with a period of performance through October 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. There is no set-aside designation associated with this specific delivery order.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.5k | 10/21/24 |